Efficacy and safety of human umbilical cord-derived mesenchymal stem cells (hUC-MSC PLEB001) for the treatment of grade II–IV steroid-refractory acute graft-versus-host disease: a study protocol for a multicenter, randomized, double-blind, placebo-controlled, phase II trial

Peer Review reports

Original Submission
31 Jul 2022	Submitted	Original manuscript
12 Sep 2022	Reviewed	Reviewer Report - Alexander Gough
14 Feb 2023	Reviewed	Reviewer Report - Nicolaus Kröger
21 Mar 2023	Author responded	Author comments - Donglin Yang
Resubmission - Version 2
21 Mar 2023	Submitted	Manuscript version 2
3 Apr 2023	Reviewed	Reviewer Report - Alexander Gough
7 Apr 2023	Reviewed	Reviewer Report - Nicolaus Kröger
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
10 Apr 2023	Editorially accepted
3 May 2023	Article published	10.1186/s13063-023-07305-0

Back to article page